Thomas Ciulla, MD
Show Description +
Thomas Ciulla, MD, describes a study designed to address an unmet need in AMD. Anti-VEGF therapy is very effective in the acute phase of AMD, Dr. Ciulla says, but the treatment is not as effective in the chronic phase. Dr. Ciulla describes a new category of drugs designed to improve visual acuity in these patients, and discusses how patients responded in the study.
Posted: 11/17/2015
Thomas Ciulla, MD
Thomas Ciulla, MD, describes a study designed to address an unmet need in AMD. Anti-VEGF therapy is very effective in the acute phase of AMD, Dr. Ciulla says, but the treatment is not as effective in the chronic phase. Dr. Ciulla describes a new category of drugs designed to improve visual acuity in these patients, and discusses how patients responded in the study.
Posted: 11/17/2015
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AAO: 2015.
Please log in to leave a comment.